GSK officially announced last Friday that it will make genomic profiling data for over 300 cancer cell lines free through the NCI's caBIG database, according to a post at Wired. Most of it is microarray data and comes from diseased breast, prostate, lung, and ovarian tissues. Says Richard Wooster, Director of Translational Medicine Oncology, R&D, in a press release, "…we hope this data will further drive the identification of predictive biomarkers and lead to shorter, more directed clinical trials allowing us to bring drugs more quickly to patients who need them."
GSK Frees Its Data
Jun 23, 2008